학술논문

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Document Type
Article
Source
In Lancet Neurology 2010 9(4):363-372
Subject
Primary Research
Articles
Language
ISSN
1474-4422